Sep. 7 at 4:30 PM
📉
$BTAI Top Loser #3
Move: down 37.1%
🔴 Financial Health: Weak • 0/100
🔴 Cash Flow Strength: Weak • Free cash flow -
$57.62M
🔴 Profitability: Weak • Net margin -10887.4%
🟡 Valuation: Not Meaningful • P/E is not meaningful because earnings are negative; P/S is 30.42
Analysis:
BioXcel Therapeutics, Inc. shows a weak financial profile.
Not financial advice.